Candidemia clinical trials at UC Davis

1 research study open to eligible people

MARIO Study: IV Echinocandin Followed by Oral Ibrexafungerp or Oral Fluconazole
“Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!”
open to eligible people ages 18 years and up
This is a multicenter, randomized, double-blind study of two treatment regimens for invasive candidiasis included candidemia. Subjects will receive intravenous echinocandin followed by oral ibrexafungerp (SCY-078) vs intravenous echinocandin followed by oral fluconazole.
Sacramento, California and other locations

Last updated: March 16, 2023

MARIO Study: IV Echinocandin Followed by Oral Ibrexafungerp or Oral Fluconazole